title: Effect of inotropic stimulation on left atrial appendage function in atrial myopathy of chronic atrial fibrillation.
abstract: Atrial fibrillation (AF) leads to remodeling of the left atrium (LA) and left atrial appendage (LAA), resulting in atrial myopathy. Reduced LA and LAA function in chronic AF leads to thrombus formation and spontaneous echo contrast (SEC). The effect of inotropic stimulation on LAA function in patients with chronic AF is unknown. LAA emptying velocity (LAAEV) and maximal LAA area at baseline and after dobutamine were measured by transesophageal echocardiography in 14 subjects in normal sinus rhythm (NSR) and 6 subjects in AF. SEC in the LA was assessed before and after dobutamine. LAAEV increased significantly in both groups. However, the LAAEV at peak dobutamine in patients with AF remained significantly lower than the baseline LAAEV in patients who were in NSR (P = 0.009). Maximal LAA area decreased significantly with dobutamine in both groups, but LAA area at peak dose of dobutamine in patients with AF remained greater than baseline area in those in NSR (P = 0.01). Despite the increase in LAAEV, SEC improved in only two of five patients. We conclude that during AF, the LAA responds to inotropic stimulation with only a modest improvement in function.
authors.affiliation: VA Medical Center, 1900 E. Main St., Danville, IL 61832, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kamalesh
authors.forename: T B
authors.initials: TB
authors.lastname: Copeland
authors.forename: S
authors.initials: S
authors.lastname: Sawada
mesh_terms: D020517:Atrial Appendage / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000000981:diagnostic imaging / Q000503:physiopathology*; D016280:Atrial Function, Right / Q000187:drug effects*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002908:Chronic Disease; D004298:Dopamine / Q000494:pharmacology*; D017548:Echocardiography, Transesophageal; D006801:Humans
chemical_list: D002316:Cardiotonic Agents; D004298:Dopamine